Chronic Heart Failure With Preserved Ejection Fraction - COngestion eValuation

Heart failure (HF) is a significant cause of death and the leading cause of hospitalization in patients over 65 years of age. Congestion is the main source of symptoms and the leading cause of hospitalization for HF. Furthermore, congestive signs identified in asymptomatic patients are associated with the risk of developing symptomatic HF. The literature supports a multi-modality / integrative evaluation of congestion, combining clinical examination, laboratory results and ultrasound evaluation. The main objective of the CHF-COV Preserved study is to identify congestion markers (clinical, biological and ultrasound) quantified during a consultation or day hospitalization for the monitoring of chronic HF with preserved left ventricular ejection fraction that are associated with the risk of all-cause death, hospitalization for acute HF or IV diuretics injection in a day hospital.

NCT Number	NCT05097898
Lead Sponsor	Central Hospital, Nancy, France
Conditions	Chronic Heart Failure, Preserved Ejection Fraction
Enrollment	200 participants
Start Date	2022-08-10
Primary Completion	2028-12-10 (estimated)
Study Completion	2029-06-10 (estimated)
Updated on ClinicalTrials.gov	2023-06-05